|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,574.00 JPY | -0.39% |
|
+9.70% | -17.88% |
| 07-17 | AstraZeneca, Daiichi Sankyo Win FDA Breakthrough Therapy Designation for Breast Cancer Drug | MT |
| 07-17 | AstraZeneca: ninth breakthrough designation for Enhertu |  |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAIICHI SANKYO COMPANY, LIMITED | Other Pharmaceuticals | -0.39% | +9.70% | -17.88% | -39.92% | +28.35% | 44B |  | |  |
- Stock Market
- Equities
- 4568 Stock
- Charts Daiichi Sankyo Company, Limited
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition